Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001415889-24-022645)

Filing Details

Accession Number:: 0001415889-24-022645
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-08-30 18:00:12
Reporting Period:: 2024-08-29

Accepted Time:: 2024-08-30 18:00:12
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1528115	Annexon Inc.	ANNX	Pharmaceutical Preparations (2834)	275414423

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1818525	Ted Yednock	C/O Annexon, Inc 1400 Sierra Point Pkwy, Bldg C, Ste 200 Brisbane CA 94005	Evp & Chief Innovation Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2024-08-29	5,500	$5.95	15,500	No	4	S	Indirect	By Spouse

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	By Spouse

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	71,365	Direct

Footnotes

The transactions reported herein were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan, adopted April 12, 2024.